Metachronous dissemination was more frequently observed in ctRAS-low and ctRAS/BRAF wild-type profiles, whereas synchronous metastatic disease was significantly enriched in ctRAS-high and ctBRAF-mutant cases (p = 0.020). Here, BRAF is linked to metastatic neoplasm.